While rare, high-penetrance mutations, such as BRCA1 and BRCA2, account for a minority of breast cancer cases, recent advancements in genomic sequencing technologies have opened new avenues for uncovering additional genetic modifiers that influence breast cancer risk. The gene discussed is BRCA2; the disease is breast cancer.